Up next

Autoplay

Radioiodine in Low-Risk Thyroid Cancer | NEJM

1 Views • 07/06/23
Share
Embed
administrator
administrator
Subscribers
0

Radioiodine is typically administered after thyroidectomy in patients with thyroid cancer, but its benefits in those with low-risk disease are controversial. New research findings are summarized in a short video.

To see the full article, follow this link: https://nej.md/3HvClQD

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay